elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36610390-18D76680-9C28-4182-9D40-98DF841ABBD3
Q36610390-18D76680-9C28-4182-9D40-98DF841ABBD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36610390-18D76680-9C28-4182-9D40-98DF841ABBD3
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study.
P2860
Q36610390-18D76680-9C28-4182-9D40-98DF841ABBD3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36610390-18D76680-9C28-4182-9D40-98DF841ABBD3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cfe094c0970428ee104fae27b3060209be20f72e
P2860
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate.